10 years’ neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the study group for evaluation of neuroblastoma screening in Europe (SENSE)-Reference-Cited by-同舟云学术

10 years’ neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the study group for evaluation of neuroblastoma screening in Europe (SENSE)

Published:1998-08 Issue:9 Volume:34 Page:1391-1397
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Erttmann R.,Tafese T.,Berthold F.,Kerbl R.,Mann J.,Parker L.,Schilling F.,Ambros P.,Christiansen H.,Favrot M.,Kabisch H.,Hero B.,Philip T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Suita S, Zaizen Y, Sera Y, et al. Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan. J Pediatr Surg 1996, 31, 555–558.

2. Hayashi Y, Ohi R, Yaoita S, et al. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 months olds. J Pediatr Surg 1995, 30, 467–470.

3. Woods WG, Tuchman M, Robison L, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996, 348, 1862–1687.

4. Kerbl R, Urban CE, Ladenstein R, et al. Neuroblastoma screening in infants postponed after six months of age: a trial to reduce ‘overdiagnosis’ and to detect cases with ‘unfavourable’ biological features. Med Pediatr Oncol 1997, 29, 1–10.

5. Chauvin F, Mathieu P, Frappaz D, et al. Screening for neuroblastoma in France: methodological aspects and preliminary observations. Med Pediatr Oncol 1997, 28, 81–91.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of genes associated with spontaneous regression of neuroblastoma;Pediatric Discovery;2023-06

2. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis;Frontiers in Oncology;2020-08-19

3. Combined analysis of RNA‐sequence and microarray data reveals effective metabolism‐based prognostic signature for neuroblastoma;Journal of Cellular and Molecular Medicine;2020-07-19

4. Measurement of Serum Neuron-Specific Enolase in Neuroblastoma: Is There a Clinical Role?;Clinical Chemistry;2020-04-30

5. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma;Cancer Medicine;2020-03-26